1. Campo E., Pileri S.A., Jaffe E.S., et al. Nodal marginal zone lymphoma. WHO classifi cation of Tumors of Haematopoietic and Lymphoid Tissues. 2017; 263–5.
2. Cook J.R., Isaacson P.G., Chott A. Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) WHO Classifi cation of Tumors of Haematopoietic and Lymphoid Tissues. 2017; 259–62.
3. Piris M.A., Isaacson P.G., Swerdlow S.H., et al. Splenic marginal zone lymphoma. WHO classifi cation of Tumors of Haematopoietic and Lymphoid Tissues. 2017; 223–6.
4. Alaggio R., Amador C., Anagnostopoulos I., et al. The 5th edition of the World Health Organization Classifi cation of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia. 2022; 36: 1720–48. DOI: 10.1038/s41375-02201620-2.
5. Dungarwalla M., Appiah-Cubi S, Kulkarni S., et al. High-grade transformation in splenic marginal zone lymphoma with circulating villous lymphocytes: the site of transformation infl uences response to therapy and prognosis. Br J Haematol. 2008; 143(1): 71–4. DOI: 10.1111/j.1365-2141.2008.07301.x.